Segment Reporting (Details) $ in Millions	3 Months Ended
	Mar. 31, 2025 USD ($) segment	Mar. 31, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	2
Segment Reporting Information [Line Items]
Impact of foreign currency fluctuations	$ (69)	$ (19)
Net sales	4,663	3,856
Cost of products sold	1,360	1,192
Selling, general and administrative expenses	1,376	1,180
Research and development expenses	403	335
Other segment items	11	9
Segment operating incom	1,582	1,159
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments	(2,288)	(1,973)
Goodwill and other intangible asset impairment charges, acquisition/divestiture-related net charges (credits), restructuring and restructuring-related net charges (credits), certain litigation-related net charges (credits) and EU MDR implementation costs	(209)	(124)
Amortization expense	(219)	(214)
Operating income (loss)	921	675
Other income (expense), net	(116)	(67)
Income (loss) before income taxes	805	608
MedSurg
Segment Reporting Information [Line Items]
Net sales	1,577	1,412
Cardiovascular
Segment Reporting Information [Line Items]
Net sales	3,085	2,445
Operating Segments
Segment Reporting Information [Line Items]
Net sales of reportable segments	4,731	3,875
Income (loss) before income taxes		608
Operating Segments | MedSurg
Segment Reporting Information [Line Items]
Net sales of reportable segments	1,598	1,417
Cost of products sold	$ 435	$ 381
Cost of products sold, percentage of net sale	27.20%	26.90%
Selling, general and administrative expenses	$ 509	$ 439
Selling, general and administrative expenses, percentage of net sale	31.80%	31.00%
Research and development expenses	$ 121	$ 107
Research and development expenses, percentage of net sale	7.50%	7.60%
Other segment items	$ 6	$ 5
Other segment items, percentage of net sale	0.30%	0.30%
Segment operating incom	$ 528	$ 485
Segment operating income, percentage of net sale	33.10%	34.20%
Operating Segments | Cardiovascular
Segment Reporting Information [Line Items]
Net sales of reportable segments	$ 3,133	$ 2,458
Cost of products sold	$ 925	$ 811
Cost of products sold, percentage of net sale	29.50%	33.00%
Selling, general and administrative expenses	$ 867	$ 740
Selling, general and administrative expenses, percentage of net sale	27.70%	30.10%
Research and development expenses	$ 282	$ 228
Research and development expenses, percentage of net sale	9.00%	9.30%
Other segment items	$ 6	$ 4
Other segment items, percentage of net sale	0.20%	0.20%
Segment operating incom	$ 1,053	$ 674
Segment operating income, percentage of net sale	33.60%	27.40%
Segment Reporting, Reconciling Item, Corporate Nonsegment
Segment Reporting Information [Line Items]
Corporate expenses, including hedging activities and impact of foreign currency fluctuations on operating income of reportable segments	$ (232)	$ (146)